跳至主要内容
临床试验/JPRN-UMIN000020617
JPRN-UMIN000020617招募中未知

tility of rivaroxaban for chronic disseminated intravascular coagulation - Utility of rivaroxaban for chronic DIC

Hidesaku Asakura, Kanazawa University School of Medicine.0 个研究点目标入组 5 人开始时间: 2016年1月19日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
5

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients with a history or serious drug allergy. 2. Patients with severe renal failure. 3. The patient, who are at risk of promoting the bleeding by administration of rivaroxaban. 4. The patients, who are presumed to die soon even though DIC is improvred. 5. The patients, who are pregnant, likely to be pregnant or breast-feeding. 6. The patients, who are not judged suitable for study patients by investigators.

研究者

发起方
Hidesaku Asakura, Kanazawa University School of Medicine.

相似试验